Literature DB >> 15181080

Testosterone metabolic clearance and production rates determined by stable isotope dilution/tandem mass spectrometry in normal men: influence of ethnicity and age.

Christina Wang1, Don H Catlin, Borislav Starcevic, Andrew Leung, Emma DiStefano, Geraldine Lucas, Laura Hull, Ronald S Swerdloff.   

Abstract

The metabolic clearance rate (MCRT) and production rate (PRT) of testosterone (T) were measured using constant infusion of trideuterated (d3) T and quantitating serum d3T by liquid chromatography-tandem mass spectrometry (LC-MS-MS). Serum unlabeled T (d0T) was measured by LC-MS-MS, and serum total T (d3T + d0T) was measured by RIA. Mean MCRR (measured by LC-MS-MS) in young white men (1272 +/- 168 liters/d) was not significantly different from young Asian men (1070 +/- 166 liters/d). Mean PRT was also not significantly different between the two ethnic groups (whites, 9.11 +/- 1.11 mg/d; Asians, 7.22 +/- 1.15 mg/d; P = 0.19 using d0T data). Both the mean MCRR (812 +/- 64 liters/d; P < 0.01) and the PRT (3.88 +/- 0.27 mg/d; P < 0.001) were significantly lower in middle-aged white men when compared with their younger counterparts. The mean MCRR and PRR calculated using serum total T or d0T data showed a diurnal variation, with levels at midday significantly higher than those measured in the evening in the young (MCRT, P < 0.01; PRT, P < 0.001) and to a lesser extent in the older men (MCRT, P < 0.05; PRT, P < 0.05 using total T and P < 0.001 using d0T data). We conclude that using LC-MS-MS to detect d3T in serum after constant infusion of stable isotope-labeled T allows the measurements of MCRT and PRT, which can be used to study androgen metabolism repeatedly after physiological or pharmacological interventions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15181080     DOI: 10.1210/jc.2003-031802

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  15 in total

Review 1.  Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?

Authors:  Manthos G Giannoulis; Finbarr C Martin; K Sreekumaran Nair; A Margot Umpleby; Peter Sonksen
Journal:  Endocr Rev       Date:  2012-03-20       Impact factor: 19.871

2.  Experimentally induced androgen depletion accentuates ethnicity-related contrasts in luteinizing hormone secretion in asian and caucasian men.

Authors:  Johannes D Veldhuis; Anthony Bae; Ronald S Swerdloff; Ali Iranmanesh; Christina Wang
Journal:  J Clin Endocrinol Metab       Date:  2004-11-30       Impact factor: 5.958

Review 3.  Anterior pituitary hormone replacement therapy--a clinical review.

Authors:  Christoph J Auernhammer; George Vlotides
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

Review 4.  Testosterone replacement therapy for late-onset hypogonadism: current trends in Korea.

Authors:  Young Hwii Ko; Je Jong Kim
Journal:  Asian J Androl       Date:  2011-05-16       Impact factor: 3.285

5.  Analysis of testosterone and dihydrotestosterone in mouse tissues by liquid chromatography-electrospray ionization-tandem mass spectrometry.

Authors:  Yan Weng; Fang Xie; Li Xu; Dmitri Zagorevski; David C Spink; Xinxin Ding
Journal:  Anal Biochem       Date:  2010-03-31       Impact factor: 3.365

Review 6.  Does ethnicity matter in male hormonal contraceptive efficacy?

Authors:  Niloufar Ilani; Peter Y Liu; Ronald S Swerdloff; Christina Wang
Journal:  Asian J Androl       Date:  2011-02-14       Impact factor: 3.285

7.  Serum Testosterone (T) Level Variability in T Gel-Treated Older Hypogonadal Men: Treatment Monitoring Implications.

Authors:  Ronald S Swerdloff; Youngju Pak; Christina Wang; Peter Y Liu; Shalender Bhasin; Thomas M Gill; Alvin M Matsumoto; Marco Pahor; Prasanth Surampudi; Peter J Snyder
Journal:  J Clin Endocrinol Metab       Date:  2015-06-29       Impact factor: 5.958

Review 8.  Male late-onset hypogonadism: pathogenesis, diagnosis and treatment.

Authors:  Ilpo Huhtaniemi; Gianni Forti
Journal:  Nat Rev Urol       Date:  2011-04-19       Impact factor: 14.432

Review 9.  Advances in male contraception.

Authors:  Stephanie T Page; John K Amory; William J Bremner
Journal:  Endocr Rev       Date:  2008-04-24       Impact factor: 19.871

10.  Combined transdermal testosterone gel and the progestin nestorone suppresses serum gonadotropins in men.

Authors:  Vahid Mahabadi; John K Amory; Ronald S Swerdloff; William J Bremner; Stephanie T Page; Regine Sitruk-Ware; Peter D Christensen; Narender Kumar; Yun-Yen Tsong; Diana Blithe; Christina Wang
Journal:  J Clin Endocrinol Metab       Date:  2009-04-14       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.